ArticleMethodsX2025
Optimizing brain tumor detection in MRI scans through InceptionResNetV2 and deep stacked Autoencoders with SwiGLU activation and sparsity regularization.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents an automated framework for brain tumor classification aimed at accurately distinguishing tumor types in MRI images. The proposed model integrates InceptionResNetV2 for feature extraction with Deep Stacked Autoencoders (DSAEs) for classification, enhanced by sparsity regularization and the SwiGLU activation function. InceptionResNetV2, pre-trained on ImageNet, was fine-tuned to extract multi-scale features, while the DSAE structure compressed these features to highlight critical attributes essential for classification. The approach achieved high performance, reaching an overall accuracy of 99.53 %, precision of 98.27 %, recall of 99.21 %, specificity of 98.73 %, and an F1-score of 98.74 %. These results demonstrate the model's efficacy in accurately categorizing glioma, meningioma, pituitary tumors, and non-tumor cases, with minimal misclassifications. Despite its success, limitations include the model's dependency on pre-trained weights and significant computational resources. Future studies should address these limitations by enhancing interpretability, exploring domain-specific transfer learning, and validating on diverse datasets to strengthen the model's utility in real-world settings. Overall, the InceptionResNetV2 integrated with DSAEs, sparsity regularization, and SwiGLU offers a promising solution for reliable and efficient brain tumor diagnosis in clinical environments.•Leveraging a pre-trained InceptionResNetV2 model to capture multi-scale features from MRI data.•Utilizing Deep Stacked Autoencoders with sparsity regularization to emphasize critical attributes for precise classification.•Incorporating the SwiGLU activation function to capture complex, non-linear patterns within the data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.